-
Mashup Score: 1What factors contribute to resistance to BCMA-targeted CAR T-cell therapies in multiple myeloma? - 1 month(s) ago
During the EHA-EBMT 6th European CAR T-cell Meeting, the Multiple Myeloma Hub spoke to Paola Neri, University of Calgary, Calgary, CA. We asked, What factors contribute to resistance to BCMA-targeted CAR T-cell therapies in multiple myeloma?
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
🎥 #CART24 | The Multiple Myeloma Hub spoke to Paola Neri @UCalgary. We asked, What factors contribute to resistance to BCMA-targeted CAR T-cell therapies in #MultipleMyeloma? Watch here: https://t.co/GZQnfQoAWi @TheEBMT @EHA_Hematology #mmsm #myeloma